IPO investors are beginning to see pre-IPO valuations. A biotech and a semiconductor company went public this past week after slashing their proposed valuations. While health care...read more
MyoKardia, a clinical-stage biotech developing therapies for heritable cardiomyopathies, raised $54 million by offering 5.4 million shares at $10.00, below the range of $15 to $17. MyoKardia plans to list on the Nasdaq under the symbol MYOK. Credit Suisse and...read more
Just one new company is scheduled to price this week. Three small initial public offerings have delayed IPOs for two weeks or more, and again join the IPO calendar. In the...read more
MyoKardia, a clinical-stage biotech developing therapies for heritable cardiomyopathies, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $75 million by offering 4.7 million shares at a price range of $15 to...read more
US IPO Weekly Recap: IPO investors get pre-IPO valuations
IPO investors are beginning to see pre-IPO valuations. A biotech and a semiconductor company went public this past week after slashing their proposed valuations. While health care...read more
MyoKardia prices IPO at $10.00, below the range
MyoKardia, a clinical-stage biotech developing therapies for heritable cardiomyopathies, raised $54 million by offering 5.4 million shares at $10.00, below the range of $15 to $17. MyoKardia plans to list on the Nasdaq under the symbol MYOK. Credit Suisse and...read more
Week ahead: As many as 4 IPOs set to price during the week of October 26
Just one new company is scheduled to price this week. Three small initial public offerings have delayed IPOs for two weeks or more, and again join the IPO calendar. In the...read more
For the brokenhearted: MyoKardia sets terms for $75 million IPO
MyoKardia, a clinical-stage biotech developing therapies for heritable cardiomyopathies, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $75 million by offering 4.7 million shares at a price range of $15 to...read more